September 22nd 2022
A panel of experts describe the clinical burden of myelodysplastic syndromes (MDS), discuss treatment paradigms and standard of care therapies, and explore unmet needs and future directions in the treatment of MDS.
August 19th 2022
A panel of experts explore the clinical and economic burden of vitiligo, review treatment paradigms and standard of care therapies, and discuss unmet needs and future directions for treatment of vitiligo.
August 10th 2022
An expert panel discusses chronic kidney disease (CKD), its impact on cardiovascular disease (CV), and the methods of treatment used on the patient populations.
July 28th 2022
A panel of experts explore the updated heart failure guidelines and the impact on current treatment landscape for patients, with a focus on evidence-based medicine, payer strategies, and collaborative care management.
April 22nd 2022
A panel of experts provide an overview of the burden of common health concerns in women’s reproductive years, review currently available treatment options, and discuss a personalized treatment approach for women’s reproductive health. Ryan Haumschild, PharmD, MBA, MS, discusses implications of the Affordable Care Act (ACA) to women’s reproductive health, along with methods to ensure timely access to appropriate therapy.
April 11th 2022
A panel of expert discuss interstitial lung disease (ILD) in depth, from definition to the best possible therapy options for treatment.
March 25th 2022
A panel of experts explore the patient journey and unmet needs of patients with treatment resistant depression (TRD), outline treatment strategies for TRD outside of oral antidepressants/antipsychotics and explore strategies to support access to these alternative therapies through improved billing/coding strategies.
February 16th 2022
A panel of clinicians and managed care decision makers describe how to best refer to real-world evidence when making treatment decisions for patients with multiple myeloma.
December 23rd 2021
Payer and clinician insight regarding the integration of comprehensive genomic profiling into routine clinical practice to help oncologists make more informed treatment decisions for patients with cancer.